Commentary · 21 Feb 2026
Conference abstractPublished 24 May 2018
Novel roles of gelsolin, a cytoskeletal protein, in regulating chemoresistance and cancer cell survival
National University of Singapore, Singapore Curtin University, Australia National University Health System, Singapore
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Colorectal cancer is one of most common types of cancer worldwide. Current first line chemotherapeutic treatment of colorectal cancer comprises 5-fluorouracil (5-FU)-based regimen. However, response to 5-FU-based therapy varies in patients and development of drug resistance also impedes the effectiveness of treatment. Therefore, there is a pressing need to understand the mechanisms of drug resistance and identify new targets to help overcome chemoresistance. Accumulating evidence suggest that regulators of actin cytoskeleton play critical roles in the resistance to treatment and disease progression, via modulating cell survival/cell death pathways. Herein, we identify that gelsolin, an actin depolymerizing factor, contributes to resistance to 5-FU in colorectal cancer cells. Using colorectal cancer cell lines, we showed that gelsolin protected cells from 5-FU-induced cell death, while reducing gelsolin levels could sensitize cells to 5-FU treatment. Furthermore, gelsolin modulated autophagy, an important cell survival process against stresses, as a cytoprotective mechanism in response to 5-FU. We also demonstrate that gelsolin could be a potential prognostic marker for colorectal cancer patients, where patients with high levels of gelsolin and autophagy-regulating proteins showed shorter disease-free survival, compared to those with lower expression levels. In summary, we demonstrated a role of gelsolin in regulating autophagy, which contributes to 5-FU resistance in colorectal cancer cells. Our findings highlight gelsolin as a potential target for combating resistance to 5-FU based chemotherapy, and as a possible prognostic factor in patient survival.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Shuo Deng”
- BylineArticles whose byline prints “Tuan Zea Tan”
- BylineArticles whose byline prints “Tamilarasi Jegadeesan”
- BylineArticles whose byline prints “Liming Wang”
- BylineArticles whose byline prints “Henry Yang”
- BylineArticles whose byline prints “Alan Prem Kumar”
- BylineArticles whose byline prints “Han-Ming Shen”
- BylineArticles whose byline prints “Celestial T Yap”

